• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE DRUG ELUTING CORONARY STENT; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE DRUG ELUTING CORONARY STENT; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number UNK XIENCE V
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Hemorrhage/Bleeding (1888); Myocardial Infarction (1969); Neurological Deficit/Dysfunction (1982); Thrombosis (2100)
Event Date 01/01/2013
Event Type  Injury  
Manufacturer Narrative
The patient deaths will be filed under a separate medwatch report #.The device was not returned for evaluation.The reported patient effect(s) of myocardial infarction and thrombosis are listed in the xience v everolimus eluting coronary stent systems instructions for use, as a known patient effect(s) of coronary stenting procedures.A review of the lot history record and complaint history of the reported lot could not be conducted because the part and lot numbers were not provided.A conclusive cause for the reported patient effect(s) of myocardial infarction, thrombosis, hemorrhage, neurological deficit and the relationship to the product, if any, cannot be determined.There is no indication of a product quality issue with respect to manufacture, design or labeling.The udi is unknown because the part and lot #s were not provided.Title: the hypercholesterolemia paradox in percutaneous coronary intervention: an analysis of a multicenter pci registryna.
 
Event Description
It was reported through a research article identifying xience v that may be related to the following: patient death, thrombosis, myocardial infarction, hemorrhage, neurological deficit.This article summarizes clinical outcomes of 1866 patients that were treated with xience v stents.Specific patient information is documented as unknown.Details are listed in the article, titled "the hypercholesterolemia paradox in percutaneous coronary intervention: an analysis of a multicenter pci registry.".
 
Manufacturer Narrative
This report is being resubmitted to ensure the enclosed attachment can be easily opened by the fda.Na - attachment: [article e-22146 cn-025820].
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE DRUG ELUTING CORONARY STENT
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9848590
MDR Text Key183956245
Report Number2024168-2020-02591
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
PMA/PMN Number
P070015
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Type of Report Initial,Followup
Report Date 07/22/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/18/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK XIENCE V
Was Device Available for Evaluation? No
Date Manufacturer Received07/20/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
Patient Age70 YR
-
-